PDX for sale!
Purchase our 3 major collections of breast, colon and lung
patient-derived xenografts along with
• Clinical data
• Molecular data for colon and breast cancer models
• Drug response data for colon and lung cancer models
Oncodesign awarded accreditation of its
research center by international
A recognition of 18 years of consultation, investment and ethical
commitment in the area of preclinical experimentation
in cancer research.
Translational biomarker approaches
to address patient needs
Pharmaco-imaging in support of therapeutic development
and for drug targeting.
State-of-the-art models for optimal
Patient-derived xenografts and human immune system
models to allow better decisions.
Next generation kinase inhibitors
with unique properties
Potent and selective Nanocyclix leads for known
and novel kinases.
A large panel of technological and scientific solutions for pharmacological qualification of your compounds : a unique oncology preclinical CRO
A platform-based approach for the discovery of novel chemical entities with therapeutic and diagnostic potential